BRCA1 and spinocerebellar ataxia, autosomal recessive, with axonal neuropathy: Association of BRCA1 promoter hypermethylation status with outcome after adjuvant chemotherapy (mainly FEC ± taxane therapy) was investigated using invasive disease-free survival (IDFS) as the primary clinical endpoint in 149 eligible SCAN-B patients (Fig. 1).